Business Context and Reporting Period
Company: National Health Investors, Inc. (NHI)
Filing Type: Form 8-K (Current Report)
Date of Report: October 24, 2024
Event: Entry into a Material Definitive Agreement (Amended and Restated Credit Agreement) and Amendment to Existing Term Loan Agreement.
Key Financial Metrics and Debt Structure
This filing details the restructuring of the Company's credit facilities rather than reporting operational financial results (revenue, profit, or cash flow) for a specific period.
- Revolving Credit Facility: Aggregate commitments of $700 million, maturing October 24, 2028.
- Outstanding Borrowings (Revolving): $307.4 million as of October 24, 2024.
- Term Loan Facility: $200 million principal amount, maturing June 16, 2025.
- Outstanding Borrowings (Term Loan): $200.0 million as of October 24, 2024.
- Additional Capacity: Option to increase commitments to $1.0 billion aggregate; up to $30 million for letters of credit and $30 million for swingline loans.
- Interest Rates: Variable based on Term SOFR, Daily SOFR, or Base Rate plus a margin ranging from 0.725% to 1.40% (or 0.00% to 0.40% for Base Rate), dependent on credit rating.
- Facility Fee: 0.125% to 0.30% on the $700 million committed capacity.
Material Changes Versus Prior Period
The Company amended and restated its existing Credit Agreement dated March 31, 2022, and amended its Term Loan Agreement dated June 16, 2023.
- Extension of Maturity: The Revolving Credit Facility maturity was extended to October 24, 2028 (from the prior 2022 agreement).
- Covenant Alignment: The Term Loan Agreement was amended to align its representations, covenants, financial covenants, and events of default with the new Credit Agreement.
- Expansion Option: Added the option to increase total loan commitments to $1.0 billion, subject to lender agreement.
Guidance, Outlook, and Covenants
The filing does not provide operational guidance or management commentary on future earnings. However, it outlines strict financial maintenance covenants required under the new agreements:
- Debt to Asset Value: Consolidated total indebtedness to consolidated total asset value ratio not to exceed 0.60 to 1.00 (0.65 to 1.00 for four quarters post-acquisition).
- Tangible Net Worth: Minimum consolidated tangible net worth of $1.475 billion.
- Fixed Charge Coverage: Consolidated EBITDA to consolidated fixed charges ratio not less than 1.50 to 1.00.
- Secured Debt Limit: Secured indebtedness to consolidated total asset value ratio not to exceed 0.30 to 1.00.
- Unsecured Debt Limit: Unsecured indebtedness to unencumbered asset value ratio not to exceed 0.60 to 1.00 (0.65 to 1.00 for four quarters post-acquisition).
- Net Operating Income Coverage: Ratio of net operating income from unencumbered assets to unsecured interest expense not less than 2.00 to 1.00.
Important Facts for Investor Verification
- Verify the Company's current credit rating to determine the specific interest rate margin and facility fee applicable.
- Confirm compliance with the new minimum tangible net worth requirement of $1.475 billion.
- Monitor the ratio of consolidated total indebtedness to consolidated total asset value to ensure it remains below the 0.60 threshold.
- Note that the Term Loan matures in June 2025, requiring refinancing or repayment within approximately 8 months of this filing.
- Review the full text of the Credit Agreement and Amendment (to be filed as exhibits to the 2024 Form 10-K) for complete terms and conditions.